SUVEN LIFE SCIENCES
|
The Current P/S Ratio of SUVEN LIFE SCIENCES is 649.75.
| Share Price | ₹167.5 | Dec 30,2025 |
| Market Cap | ₹3,809.5 Cr | |
| Sales-TTM | ₹5.9 Cr | TTM-Consolidated Results |
| Price/Sales | 649.75x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SUVEN LIFE SCIENCES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹3,809.5 Cr] as on Dec 30,2025
(/) Sales [ ₹5.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 649.75x ]
Thus, for SUVEN LIFE SCIENCES , the investors are currently willing to pay '649.75 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUVEN LIFE SCIENCES !
The chart below summarizes the trend in P/S Ratio of SUVEN LIFE SCIENCES over the last five years.
Historical PS (Price/Sales) ratio chart of SUVEN LIFE SCIENCES
PS Ratio Performance Analysis for SUVEN LIFE SCIENCES
- SUVEN LIFE SCIENCES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 163.18x.
- SUVEN LIFE SCIENCES 's operated at median p/e ratio of 113.85x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUVEN LIFE SCIENCES 's p/e ratio peaked in Mar2025 at 371.55x.
- SUVEN LIFE SCIENCES 's p/e ratio hit its five-year low in Mar2021 of 66.48x.
How does SUVEN LIFE SCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SUVEN LIFE SCIENCES | 5.9 | 649.75 | 3,809.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.51 | 412,590.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 17.01 | 170,577.0 |
| CIPLA LTD | 28,349.6 | 4.25 | 120,471.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.56 | 129,301.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.08 | 105,660.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.55 | 88,885.2 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.70 | 90,691.9 |
| LUPIN LTD | 24,750.7 | 3.84 | 95,059.8 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.12 | 68,952.8 |
| ABBOTT INDIA LTD | 6,714.4 | 9.02 | 60,580.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SUVEN LIFE SCIENCES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.12x |
| Max industry PS | 649.75x |
| Median industry PS | 6.55x |
| Average industry PS | 65.22x |
You may also like the below Video Courses